STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Dave Inc./DE SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Form 144 notice from the holder of DAVE common stock proposes to sell 50,000 shares through Morgan Stanley Smith Barney LLC on the NASDAQ. The filing shows the shares were acquired in a private transaction from the issuer on 08/09/2023 and were paid for in cash. The proposed sale has an aggregate market value of $11,471,000 and the issuer reports 12,084,643 shares outstanding, with an approximate sale date listed as 09/15/2025. The filer certified no undisclosed material adverse information and indicated no securities of the issuer were sold by the account in the past three months.

Positive
  • Full Rule 144 disclosure provided with acquisition details, broker, proposed sale date, and outstanding shares
  • Securities were paid in cash at acquisition (08/09/2023), simplifying provenance of the position
  • Brokerage route documented: Morgan Stanley Smith Barney LLC named as the executing broker
Negative
  • High aggregate sale value of $11,471,000 may be material to some stakeholders given its dollar size
  • No trading-plan date is indicated, so the sale appears to be a proposed open-market disposition rather than a 10b5-1 plan

Insights

TL;DR: Insider plans to sell 50,000 DAVE shares (proposed value $11.47M) via a major broker; disclosure is routine but material in dollar terms.

The filing documents a proposed sale of 50,000 common shares through Morgan Stanley Smith Barney on NASDAQ with an aggregate market value of $11,471,000. The shares were acquired in a private transaction and paid in cash on 08/09/2023. For investors, the key facts are the size of the position being offered and that no other sales by the account were reported in the past three months. This is a standard Rule 144 notification providing required transparency for an officer/director/affiliate or other covered person preparing to sell restricted or control securities.

TL;DR: Filing meets Rule 144 disclosure elements; signer attests no undisclosed material adverse information.

The form includes required acquisition details (private transaction, cash payment), broker information, number of shares outstanding, and an attestation regarding material disclosures. The presence of a major brokerage firm and the explicit representation about material information align with standard compliance expectations. The document does not report any sales in the prior three months, and no trading plan date is provided on the form.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the DAVE Form 144 disclose about the proposed sale?

The filer proposes to sell 50,000 common shares of DAVE via Morgan Stanley Smith Barney on NASDAQ, with an aggregate market value of $11,471,000 and an approximate sale date of 09/15/2025.

When and how were the shares being sold acquired?

The shares were acquired on 08/09/2023 in a private transaction from the issuer and were paid for in cash on that date.

Does the filing report recent sales of DAVE shares by the same account?

No. The filing states "Nothing to Report" for securities sold during the past three months by the account.

What compliance representation does the filer make in the Form 144?

The filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed and signs the notice under that attestation.

Through which broker is the proposed sale to be executed?

Morgan Stanley Smith Barney LLC, Executive Financial Services, New York is named as the broker in the filing.
DAVE INC

NASDAQ:DAVE

DAVE Rankings

DAVE Latest News

DAVE Latest SEC Filings

DAVE Stock Data

2.92B
10.57M
13.18%
84.42%
10.33%
Software - Application
Finance Services
Link
United States
LOS ANGELES